Takeda opens R&D facility in San Diego, California

pharmafile | May 2, 2019 | News story | Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego 

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 staff.

The new facility will be focused on drug discovery in the areas of neuroscience and gastroenterology (GI).

The centre houses research platform groups across structural and computational biology, early target discovery and biologics for the advancement of potential molecules.

Takeda hopes the facility will supplement its R&D centres in Cambridge, Massachusetts and Shonan, Japan.

Takeda Pharmaceutical Research head Steve Hitchcock commented: “Our San Diego research centre demonstrates an ideal balance between highly specialised internal research competencies and dedication to external partnerships both within the local community and on a global scale.”  

“By consulting with and leveraging our relationships with academic and industry partners and patient groups, we are able to operate nimbly and efficiently to advance early discovery research that could potentially translate into transformative, life-changing therapies for patients in need, complementing our efforts in our other global research centres in Cambridge and Shonan.”

Louis Goss

Related Content

robina-weermeijer-ihfopazzjhm-unsplash_5

MHRA approves Takeda’s Hyqvia for chronic inflammatory demyelinating polyneuropathy treatment

Takeda has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing …

minku-kang-acnintiifd8-unsplash_1

Proteome Sciences completes new facility in San Diego, US

Proteome Sciences has announced that it has completed the installation and set up of equipment …

Pharmanovia acquires CNS portfolio from Sanofi

Pharmanovia has announced that it will expand its neurology portfolio with the acquisition of a …

Latest content